News
2017
-
Group Company
General
November 1, 2017
-
Taisho Pharmaceutical Appointed Official Sponsor of Rugby World Cup 2019™ Japan
-
Holdings
Investors
October 30, 2017
-
Reference Data
-
Holdings
Investors
October 30, 2017
-
Financial Results for the 2nd Quarter of Fiscal 2017
-
Holdings
Investors
October 25, 2017
-
Notice of Revision of Half-Year Forecasts for the Fiscal Year Ending March 31, 2018
-
Group Company
Corporate
October 13, 2017
-
Transfer of rights to anti-rheumatic agent KOLBET® Tablets in Japan
-
Holdings
Corporate
August 3, 2017
-
Notice Concerning Determination of Details of Stock Options
-
Holdings
Investors
August 2, 2017
-
Reference Data
-
Holdings
Investors
August 2, 2017
-
Financial Results for the 1st Quarter of Fiscal 2017
-
Holdings
Corporate
June 29, 2017
-
Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
-
Holdings
Investors
May 15, 2017
-
Reference Data
-
Holdings
Investors
May 15, 2017
-
Financial Statements for Fiscal 2016
-
Holdings
Investors
February 2, 2017
-
Reference Data
-
Holdings
Investors
February 2, 2017
-
Financial Results for the 3rd Quarter of Fiscal 2016
-
Holdings
Corporate
January 31, 2017
-
"Notice Concerning the Termination of the Agreement Between Taisho Pharmaceutical Co., Ltd.
and Takeda Pharmaceutical Co., Ltd. on the Distribution of the OTC Drugs and Quasi-Drugs of Biofermin Pharmaceutical Co., Ltd."